NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Net margin 2016–2021
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) net profit margin by fiscal year — reported net income divided by reported revenue.
-250740.0%FY2021 · since FY2016: -474.8% → -250740.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -250740.0% | -240621.0 pp |
| FY2020 | -10119.0% | -5717.0 pp |
| FY2019 | -4402.0% | +327.5 pp |
| FY2018 | -4729.5% | -0.9 pp |
| FY2017 | -4728.5% | -4253.7 pp |
| FY2016 | -474.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NYMXF financial trends
NYMXF RevenueNYMXF Net incomeNYMXF Gross profitNYMXF Gross marginNYMXF Operating incomeNYMXF Operating marginNYMXF Operating cash flowNYMXF Free cash flowNYMXF Capital expendituresNYMXF Return on equityNYMXF Stock buybacksNYMXF Dividends paidNYMXF Total assetsNYMXF Total liabilitiesNYMXF Shareholders’ equityNYMXF overview →